SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending as the community anticipates upcoming earnings, with some analysts predicting the stock could double its market cap. Bullish sentiment abounds, with some traders drawing comparisons to other high-growth tech stocks. However, concerns about high valuation and potential for a post-earnings pullback remain discussion points.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is surging on news of a massive, multi-year AI cloud services agreement with Microsoft, driving significant community excitement. Investors are drawing parallels to similar deals in the sector, anticipating a substantial upside, while also highlighting the company's strategic positioning in the AI infrastructure space. The conversation also involves speculation around potential earnings catalysts and further expansion opportunities.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

LCID is trending amid concerns about its financial health and the overall EV market, despite partnerships with Nvidia and Uber. The community is discussing potential dilution, comparing it unfavorably to Tesla, and questioning its long-term viability. Bearish sentiment seems to be dominating, with some anticipating further declines and new all-time lows.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as traders discuss whether it's setting up for a similar breakout to Amazon, focusing on accumulation patterns and potential FOMO. Some investors are frustrated with the stock's recent performance despite positive earnings, while others see it as an undervalued long-term play, especially with upcoming events like the World Cup and Olympics.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

LLY is trending as investors digest recent news, including strong phase 3 data for its oral GLP-1 orforglipron and potential impacts from government negotiations on drug pricing. Community discussions revolve around the drug's potential, target prices, and the ongoing competition within the weight loss and diabetes markets. Some are also discussing potential deals in the sector.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is trending following positive clinical data from its TERN-701 trial, selected for oral presentation at an upcoming hematology conference, driving speculation of a potential buyout. Community members are weighing the bullish data against a recent $300M shelf registration, debating short-squeeze potential versus dilution risks. The focus shifts to TERN's oncology program after the discontinuation of their GLP-1 candidate, with some viewing it as a streamlined path to acquisition.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a mix of factors, including reactions to a recent lawsuit against a former colleague and anticipation of upcoming earnings. The community is actively discussing the potential impact of these events, with some speculating about leaked results and others focused on technical analysis and potential price movements. Overall, the sentiment is mixed, with both bullish and bearish viewpoints expressed.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to a volatile reaction to recent FDA feedback regarding its Huntington's disease treatment, AMT-130; while the company believes the FDA is aligned for accelerated approval, the agency has voiced concerns around data adequacy. The community is actively debating the FDA's shifting stance, potential delays, and the overall implications for the company's future, with some suggesting a possible buyout while some expect that $QURE is overvalued.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences ($ENVB) is trending due to community discussion around its low float, with many eyeing the stock for potential short squeeze opportunities similar to other recent runners. Speculation includes potential news catalysts and a possible shift in focus towards digital asset treasury strategies. Some investors are also highlighting the company's intellectual property and potential settlement opportunities with AbbVie.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana (SOL) is trending as the community discusses its potential to recapture higher price levels, with some eyeing key demand zones for potential bounces. Technical analysis is being shared, with traders watching for breakouts or breakdowns from current levels. Bullish sentiment remains for the long term, with some highlighting Solana's fundamentals and real-world asset tokenization potential.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Layoffs and a top exec out: what GM pullback on EVs means for you

General Motors recently took its biggest step yet to address a slowing electric car industry, and it's not a minor one.GM has halted battery manufacturing in Ohio and Tennessee and reduced one of...

lululemon Dips Below 50-Day SMA: Buy Now or Stay on the Sidelines?

LULU slips below key technical levels as weak U.S. sales, tariff pressures and soft guidance weigh on investor sentiment.

China's Strength, Strain in the US: Can lululemon Keep Pace?

LULU's China expansion accelerates with rising sales, new stores and digital engagement, fueling its global growth ambitions.

JCPenney borrows bold Macy's strategy to boost holiday sales

With the holidays fast approaching, retailers are doing everything in their power to stand out during the busiest shopping season of the year. As the retail industry navigates economic uncertainty...

Target's next CEO finds a bold solution to alarming sales declines

Target was once one of the top retailers nationwide. Collaborations with major fashion brands were a big draw for many consumers. The partnerships offered customers high-quality, stylish, and...

Lululemon just found a new arena, and it's not the gym

Lululemon is entering new territory with the National Football League by creating a line of high-end supporter clothing. For fans of the brand and investors in LULU stock, the partnership with such...

Lululemon (LULU) Stock Moves -5.38%: What You Should Know

Lululemon (LULU) closed at $170.3 in the latest trading session, marking a -5.38% move from the prior day.

Lululemon is selling $98 leggings for just $39 that are 'comfortable' and 'flattering'

TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission.Why we love this productAnyone who owns a pair of leggings knows the...

Can NIKE's Athlete-Led Storytelling Strategy Win Back Market Share?

NKE doubles down on athlete-led storytelling to reignite its brand and reconnect performance, culture and consumer passion.

<ul class="summary-bullets"><li>The NFL said that beginning October 28, customers can buy the new collection from the NFL shop and Fanatics websites as well as team retail locations, including online and at stadium retail stores.</li><li>The collection will feature iconic Lululemon pieces across men’s and women’s apparel and accessories, all of which include signature team marks.&nbsp;</li><li>Jefferies said that Lululemon's decision to partner with Fanatics to sell NFL apparel is a "questionable move" that signals deeper strategic confusion.</li></ul>Lululemon Athletica (LULU) stock became one of the top-trending tickers on Stocktwits after the shares rose nearly 3% on Monday following the announcement of a partnership with the National Football League (NFL) and the launch of an elevated apparel collection for all 32 NFL teams.The NFL said that it was the first time the retailer has offered officially licensed products for the NFL or any of its teams. The collection will feature iconic Lululemon pieces across men’s and women’s apparel and accessories, all of which include signature team marks.&nbsp;Retail sentiment on Lululemon jumped to ‘bullish’ from ‘neutral’ territory compared to a day ago, with message volumes at ‘high levels, according to data from Stocktwits.<h2 class="st-heading-2">What Does The Partnership Entail?</h2>The NFL said that beginning October 28, customers can buy the new collection from the NFL shop and Fanatics websites as well as team retail locations, including online and at stadium retail stores.The assortment features core Lululemon products from its Steady State men’s franchise, as well as women’s styles from Define, Scuba, and Align, among others.<h2 class="st-heading-2">Jefferies Calls The NFL Partnership 'Questionable'</h2>Lululemon's decision to partner with Fanatics to sell NFL apparel is a "questionable move" that signals deeper strategic confusion, Jefferies said on Monday.The firm has an ‘Underperform’ rating on Lululemon and $120 price target on the shares, according to TheFly. Jefferies noted that the partnership highlights Lululemon's pattern of pursuing non-core growth at the expense of brand clarity, risking further erosion of its premium positioning.In early September, Lululemon’s management acknowledged product missteps and a struggling U.S. business. The company is also seeing a potential deceleration in the China business.<a href="https://stocktwits.com/symbol/LULU">Shares of Lululemon</a> have lost nearly 53% of their value this year and 41% over the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/government-shutdown-results-in-over-1660-flight-delays-nationwide-on-monday-report/cLG0Xe2R3uB">Government Shutdown Results In Over 1,660 Flight Delays Nationwide On Monday: Report</a>

 A Lululemon corporate logo hangs on the front of their store in Brookfield Place on June 21, 2023, in New York City. (Photo by Gary Hershorn/Getty Images)

Lululemon Stock Jumps On NFL Partnership But Jefferies Calls The Move ‘Questionable’

The NFL said that the collection will feature iconic Lululemon pieces across men’s and women’s apparel and accessories, all of which include signature team marks.

Equity

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

LULU
Lululemon Athletica Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LULU News

LULULululemon Athletica Inc